PATENT CLAIM ANALYSIS

Application Number: 15874938
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["530", "387300"]

Abstract:
The present invention relates to biological materials against P2X7 and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the biological materials of the present invention inhibit the biological activity of the P2X7 receptor, such as activation by ATP.

Claim (Index 38):
The polypeptide according to  claim 29 , wherein said immunoglobulin single variable domain consists of a domain antibody, an amino acid sequence that is suitable for use as a domain antibody, a single domain antibody, an amino acid sequence that is suitable for use as a single domain antibody, a dAb, an amino acid sequence that is suitable for use as a dAb, a Nanobody, a VHH sequence, a humanized VHH sequence or a camelized VH sequence.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.82979
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14403754', '14382027', '13937718', '15562437', '14402301']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6652084149569581
- 35 USC 102 Novelty (BERT): 0.7176873316311663
- Combined Prediction Score: 0.6704563066243789
- Mean Citation Score: 459.27668400000016
- Max Citation Score: 830.6749
- Similarity Product: 741.2297883812488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test